Clinical trial
Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk…
NCT00135902 · The George Washington University Biostatistics Center, Other · Completed
Key facts
| NCT number | NCT00135902 |
|---|---|
| Title | Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies |
| Official title | A Randomized Trial of Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in Pregnancies at High Risk |
| Lead sponsor | The George Washington University Biostatistics Center, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Preterm Birth |
| Intervention type | Drug |
| Interventions | 17 alpha-Hydroxyprogesterone Caproate and Omega-3 supplement, 17 alpha-hydroxy progesterone caproate and Placebo supplement |
| Enrollment | 800 |
| Start date | Feb 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2008 |
| First posted | Aug 26, 2005 |
| Last update posted | Jul 12, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: